JMP Securities analyst Devin Ryan maintained a Hold rating on Piper Sandler (PIPR – Research Report) today. The company’s shares closed yesterday at $271.44. According to TipRanks, Ryan is a ...

MINNEAPOLIS, September 16, 2024--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Steve Tipler as a managing director in the ...

On Tuesday, Piper Sandler maintained its Overweight rating and $30.00 price target on Central Pacific Financial (NYSE:NYSE:CPF), following a series of investor meetings last week with the company ...

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of Joe Kinder and Brent Blevins as managing directors to its public finance team. Kinder and ...

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of Joe Kinder and Brent Blevins as managing directors to its public finance team. Kinder and ...

Piper Sandler has reaffirmed its Overweight rating and $18.00 price target for Tango Therapeutics Inc. (NASDAQ: TNGX), following recent data presentations. Tango Therapeutics, a biotechnology ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Insulet (PODD – Research Report) today and set a price target of $285.00. The company’s shares closed yesterday at $233.89.

9, 2024 /PRNewswire/ -- Scientia Vascular, a leader in neurovascular innovation, is pleased to announce the closing of a $14 million growth financing led by Piper Sandler Merchant Banking.

Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) turned lower on Wednesday after Piper Sandler downgraded the company, citing a more muted growth trajectory for Qelbree, its treatment for ...

Fintel reports that on September 6, 2024, Piper Sandler upgraded their outlook for Intra-Cellular Therapies (NasdaqGS:ITCI) from Neutral to Overweight. As of August 26, 2024, the average one-year ...